New anti-obesity medicines can help stem the rising tide of obesity. But outdated rules make access to these new medicines ...

The latest generation of weight-loss drugs—the likes of Wegovy, Ozempic and Maunjaro from the stables of Novo Nordisk and ...

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

Data from the US FDA's Adverse Event Reporting System on tirzepatide showed adverse events generally consistent with those ...

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular ...

Recently revealed trial results for Roche's experimental weight-management drug suggest Viking Therapeutics is on the right ...

While GLP-1 medications like Ozempic and Wegovy hold promise for both weight loss and diabetes management, their potential for accidental misuse requires caution.

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular ...

Weight-loss drugs such as Ozempic could play a pivotal role in what Sir Keir Starmer is claiming will be the biggest shake-up ...